Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
However, the discontinuation rates for Danuglipron across different doses were over 50%, significantly higher than the approximately 40% observed in the placebo group, indicating poor tolerability in some patients
Eur J Endocrinol (2014) 220:R3755
We provide optimal absorption for superior biotherapeutic results at a price that does not cost the earth
Additionally, it improves glycemic control by stimulating insulin secretion and inhibiting glucagon release
Check kidney markers at baseline, 4 weeks, 12 weeks, and every 3 months thereafter
US$ 27.33
US$ 21.55
US$ 22.03
US$ 29.60
